Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.60 |
| ▸ | CA9 | Q16790 | 4/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 5/20 | 0.41 |
| ▸ | DDO | Q99489 | 3/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD4 | P21917 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL470073 | 1.00 | CA12 (0.60) | CA12CA9CA1CA3CA4 | |
| SCHEMBL3795510 | 0.98 | CA12 (0.58) | CA12CA9CA1CA3CA4 | |
| SCHEMBL3792963 | 0.98 | CA12 (0.58) | CA12CA9CA1CA3CA4 | |
| SCHEMBL29186655 | 0.98 | CA12 (0.58) | CA12CA9CA1CA3CA4 | |
| Sulfuric Acid SCHEMBL9438660 | 0.93 | CA12 (0.53) | CA12CA9CA1CA3CA4 | |
| SCHEMBL30714888 | 0.86 | CA12 (0.55) | CA12CA9CA1CA3CA4 | |
| SCHEMBL14236946 | 0.86 | CA12 (0.55) | CA12CA9CA1CA3CA4 | |
| Oxyquinoline SCHEMBL2133342 | 0.80 | KDM4E (0.68) | CA12CA9CA1DAOKDM4E | |
| SCHEMBL16050842 | 0.77 | CA12 (0.62) | CA12CA9CA1CA3CA4 | |
| SCHEMBL4178782 | 0.75 | CA12 (1.00) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12427231-B2 | Protected magnesium alloys for bioresorbable stents | MEDTRONIC VASCULAR, INC. (US) | 2025-09-30 | — | — | US | claimed |
| CN-114933615-B | Nitrosyl ruthenium complex with different configurations and with chiral proline and 8-hydroxyquinoline as ligands, and preparation method and application thereof | 山西大学 | 2023-09-22 | — | — | CN | claimed |
| CN-116478214-A | Nitrosyl ruthenium complex with 8-hydroxyquinoline and pyrazinamide as ligands, and preparation method and application thereof | 山西大学 | 2023-07-25 | — | — | CN | claimed |
| US-20230001057-A1 | PROTECTED MAGNESIUM ALLOYS FOR BIORESORBABLE STENTS | MEDTRONIC VASCULAR, INC. | 2023-01-05 | — | — | US | claimed |
| CN-114933615-A | Nitrosyl ruthenium complex with different configurations and taking chiral proline and 8-hydroxyquinoline as ligands as well as preparation method and application of nitrosyl ruthenium complex | 山西大学 | 2022-08-23 | — | — | CN | claimed |
| EP-3256464-B1 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2022-05-11 | — | — | EP | claimed |
| EP-4719412-A1 | 2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS | Westol, LLC (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12427231-B2 | Protected magnesium alloys for bioresorbable stents | MEDTRONIC VASCULAR, INC. (US) | 2025-09-30 | — | — | US | disclosed |
| CN-120136612-A | Modified nano double-chelated water-soluble fertilizer with medium trace elements | 菏泽开发区曹州农用化学有限公司 | 2025-06-13 | — | — | CN | disclosed |
| WO-2024249983-A1 | 2,8-DIHYDROXYQUINOLINE GLUCURONIDE DERIVATIVES WITH ENHANCED PROPERTIES FOR USE AS ANTICANCER, ANTIVIRAL, ANTIMICROBIAL, AND OTHER THERAPEUTIC APPLICATIONS | WESTOL, LLC (US) | 2024-12-05 | — | — | WO | disclosed |
| CN-114933615-B | Nitrosyl ruthenium complex with different configurations and with chiral proline and 8-hydroxyquinoline as ligands, and preparation method and application thereof | 山西大学 | 2023-09-22 | — | — | CN | disclosed |
| CN-116478214-A | Nitrosyl ruthenium complex with 8-hydroxyquinoline and pyrazinamide as ligands, and preparation method and application thereof | 山西大学 | 2023-07-25 | — | — | CN | disclosed |
| US-20230001057-A1 | PROTECTED MAGNESIUM ALLOYS FOR BIORESORBABLE STENTS | MEDTRONIC VASCULAR, INC. | 2023-01-05 | — | — | US | disclosed |
| WO-2022175982-A1 | A PROCESS FOR PREPARING BATEFENTEROL AND INTERMEDIATES THEREOF | GBR LABORATORIES PRIVATE LIMITED (IN) | 2022-08-25 | — | — | WO | disclosed |
| CN-114933615-A | Nitrosyl ruthenium complex with different configurations and taking chiral proline and 8-hydroxyquinoline as ligands as well as preparation method and application of nitrosyl ruthenium complex | 山西大学 | 2022-08-23 | — | — | CN | disclosed |
| WO-2022172292-A1 | A PROCESS FOR PREPARING ABEDITEROL AND INTERMEDIATES THEREOF | GBR LABORATORIES PRIVATE LIMITED (IN) | 2022-08-18 | — | — | WO | disclosed |
| CN-114805200-A | Procaterol hydrochloride impurity, and preparation method and application thereof | 天津泰普制药有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114452250-A | Procaterol hydrochloride oral liquid and preparation method thereof | 澳美制药(苏州)有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-110087729-B | Bifunctional compound with quaternary ammonium salt structure | 北京硕佰医药科技有限责任公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-3946599-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING | Neuropore Therapies, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |